Literature DB >> 32767654

LDL receptor-related protein LRP6 senses nutrient levels and regulates Hippo signaling.

Wonyoung Jeong1, Soyoung Kim1, Ukjin Lee1, Zhendong A Zhong2, Mikhail Savitsky3, Hyeryun Kwon1, Jiyoung Kim1, Taebok Lee4, Jin Won Cho5, Bart O Williams2, Vladimir L Katanaev3,6, Eek-Hoon Jho1.   

Abstract

Controlled cell growth and proliferation are essential for tissue homeostasis and development. Wnt and Hippo signaling are well known as positive and negative regulators of cell proliferation, respectively. The regulation of Hippo signaling by the Wnt pathway has been shown, but how and which components of Wnt signaling are involved in the activation of Hippo signaling during nutrient starvation are unknown. Here, we report that a reduction in the level of low-density lipoprotein receptor-related protein 6 (LRP6) during nutrient starvation induces phosphorylation and cytoplasmic localization of YAP, inhibiting YAP-dependent transcription. Phosphorylation of YAP via loss of LRP6 is mediated by large tumor suppressor kinases 1/2 (LATS1/2) and Merlin. We found that O-GlcNAcylation of LRP6 was reduced, and the overall amount of LRP6 was decreased via endocytosis-mediated lysosomal degradation during nutrient starvation. Merlin binds to LRP6; when LRP6 is less O-GlcNAcylated, Merlin dissociates from it and becomes capable of interacting with LATS1 to induce phosphorylation of YAP. Our data suggest that LRP6 has unexpected roles as a nutrient sensor and Hippo signaling regulator.
© 2020 The Authors.

Entities:  

Keywords:  zzm321990YAPzzm321990; Hippo signaling; LRP6; O-GlcNAcylation; Starvation

Mesh:

Substances:

Year:  2020        PMID: 32767654      PMCID: PMC7507029          DOI: 10.15252/embr.202050103

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  58 in total

1.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling.

Authors:  M Wehrli; S T Dougan; K Caldwell; L O'Keefe; S Schwartz; D Vaizel-Ohayon; E Schejter; A Tomlinson; S DiNardo
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

2.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

3.  YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.

Authors:  Luca Azzolin; Tito Panciera; Sandra Soligo; Elena Enzo; Silvio Bicciato; Sirio Dupont; Silvia Bresolin; Chiara Frasson; Giuseppe Basso; Vincenza Guzzardo; Ambrogio Fassina; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2014-06-26       Impact factor: 41.582

4.  The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

Authors:  Jianbin Huang; Shian Wu; Jose Barrera; Krista Matthews; Duojia Pan
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

5.  Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.

Authors:  Yuko Tashima; Pamela Stanley
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

6.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

7.  O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.

Authors:  Takahiro Isono
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

8.  RAP2 mediates mechanoresponses of the Hippo pathway.

Authors:  Zhipeng Meng; Yunjiang Qiu; Kimberly C Lin; Aditya Kumar; Jesse K Placone; Cao Fang; Kuei-Chun Wang; Shicong Lu; Margaret Pan; Audrey W Hong; Toshiro Moroishi; Min Luo; Steven W Plouffe; Yarui Diao; Zhen Ye; Hyun Woo Park; Xiaoqiong Wang; Fa-Xing Yu; Shu Chien; Cun-Yu Wang; Bing Ren; Adam J Engler; Kun-Liang Guan
Journal:  Nature       Date:  2018-08-22       Impact factor: 49.962

Review 9.  Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.

Authors:  Neha M Akella; Lorela Ciraku; Mauricio J Reginato
Journal:  BMC Biol       Date:  2019-07-04       Impact factor: 7.431

10.  Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance.

Authors:  Xiaoyong Yang; Pat P Ongusaha; Philip D Miles; Joyce C Havstad; Fengxue Zhang; W Venus So; Jeffrey E Kudlow; Robert H Michell; Jerrold M Olefsky; Seth J Field; Ronald M Evans
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

View more
  4 in total

1.  LRP6 lets Merlin go in times of nutrient scarcity.

Authors:  Kenneth Kin Lam Wong; Esther M Verheyen
Journal:  EMBO Rep       Date:  2020-08-20       Impact factor: 8.807

2.  LDL receptor-related protein LRP6 senses nutrient levels and regulates Hippo signaling.

Authors:  Wonyoung Jeong; Soyoung Kim; Ukjin Lee; Zhendong A Zhong; Mikhail Savitsky; Hyeryun Kwon; Jiyoung Kim; Taebok Lee; Jin Won Cho; Bart O Williams; Vladimir L Katanaev; Eek-Hoon Jho
Journal:  EMBO Rep       Date:  2020-08-07       Impact factor: 8.807

3.  Scrapie-Responsive Gene 1 Promotes Chondrogenic Differentiation of Umbilical Cord Mesenchymal Stem Cells via Wnt5a.

Authors:  Yuchuan Zhou; Tian Zheng; Lin Li; Yangfang Guo; Jiayu Xiao; Jin Wang; Zhiqin Du; Hui Gao; Weiwei Tang; Liusan Yang; Haiyan Hu; Xiaodan Wang; Mingyao Meng; Zongliu Hou
Journal:  Stem Cells Int       Date:  2022-01-27       Impact factor: 5.443

Review 4.  O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway.

Authors:  Eunah Kim; Jeong Gu Kang; Eek-Hoon Jho; Won Ho Yang; Jin Won Cho
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.